Valacyclovir Dosing for HSV-1 Infections

Clinical Presentation-Specific Dosing

• The Centers for Disease Control and Prevention recommends valacyclovir 1 gram twice daily for 7-10 days for initial genital herpes episodes, with treatment being most effective when started within 48 hours of symptom onset, and may be extended if healing is incomplete after 10 days 1, 2
• Note that 5-30% of first-episode genital herpes cases are caused by HSV-1, though clinical recurrences are much less frequent for HSV-1 than HSV-2 1, 2

Severe HSV-1 Infections

• For severe mucosal HSV-1 infections, higher dosages may be required, though clinical experience with valacyclovir for these indications is limited 1, 2
• For severe disease requiring hospitalization, IV acyclovir 5-10 mg/kg every 8 hours for 5-7 days should be used instead of oral valacyclovir 4

Special Populations

• For HIV-infected patients with CD4+ count ≥100 cells/mm³, the CDC recommends valacyclovir 500 mg twice daily for suppressive therapy, with higher dosing recommended for immunocompromised patients due to potentially more severe and frequent recurrences 3
• Avoid valacyclovir doses of 8 grams per day in immunocompromised patients due to risk of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome 3, 4

Treatment Failure and Resistance

• If lesions persist despite appropriate valacyclovir treatment, consider HSV resistance, and note that all acyclovir-resistant HSV strains are also resistant to valacyclovir 3, 4
• For acyclovir-resistant HSV, IV foscarnet 40 mg/kg every 8 hours until clinical resolution is the treatment of choice 3, 4

Important Clinical Considerations

• Suppressive therapy reduces but does not eliminate asymptomatic viral shedding, according to the CDC 3
• HSV-1 genital infections have much less frequent clinical recurrences than HSV-2, which has important prognostic and counseling implications 1, 2